‹ All Posts
Kundan Motwani

7th Nov · SEBI-Registered Analyst

Sai Life Sciences Q2 Highlights
SAILIFE

Revenue rose 35.9% to Rs 537 crore versus Rs 396 crore. Ebitda was up 42.6% at Rs 146 crore versus Rs 102 crore. Margin improved to 27.1% versus 25.8%. Net Profit more than doubled to Rs 83.8 crore versus Rs 41.5 crore.

#WatchOutFor#StockInNews
821 likes·65 comments